Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
Apolipoprotein A1 is the main protein component of HDL, often called the good cholesterol. It helps move cholesterol away from tissues and blood vessel walls to the liver for removal, a process known as reverse cholesterol transport. Your body makes Apo A1 primarily in the liver and intestines.
This blood test measures how much Apo A1 is in your circulation. It is often ordered alongside a lipid panel or with apolipoprotein B to add context about your cholesterol profile and cardiovascular health. The test reflects your current physiology; it is not a genetic test.
Apo A1 gives insight into the protective side of your cholesterol transport system. Lower amounts can be associated with a higher chance of artery plaque buildup, while higher amounts may reflect more efficient cholesterol removal. Clinicians use Apo A1 to help evaluate cardiovascular risk, especially when traditional cholesterol results are hard to interpret or when triglycerides are elevated.
The test may be ordered if you have a personal or family history of early heart disease, features of metabolic syndrome, suspected inherited HDL disorders, or to monitor response to lifestyle changes or medications. Apo A1 can also be influenced by noncardiac conditions such as liver or kidney disease and systemic inflammation, so your healthcare professional interprets it together with your history, examination, and other labs.
Your result is interpreted by comparing it to the laboratory’s reference range, which accounts for sex. A single result rarely gives the full picture. Your clinician may consider repeating the test, reviewing your lipid panel, or checking related markers such as apolipoprotein B, depending on your overall risk and goals.
If your Apo A1 is lower than expected, your care team may look for reversible causes like smoking, poorly controlled diabetes, or inflammation, and discuss lifestyle steps and medications that can improve your lipid profile. If it is higher than expected, it may reflect treatment response or physiologic factors such as pregnancy or certain hormones. In all cases, decisions are based on your overall risk, symptoms, and preferences, not the lab value alone.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Fasting is usually not required for Apo A1, but very recent high-fat meals can modestly shift lipid-related proteins. Try to have your blood drawn under similar conditions if it is being repeated for comparison.
Infections, surgery, and other inflammatory states can temporarily lower Apo A1. If you were ill around the time of testing, your clinician may advise retesting once you have recovered.
Statins, fibrates, and estrogen therapy can raise Apo A1, while androgens and some anabolic steroids can lower it. Other drugs that affect lipids may also influence results, so share a complete medication list.
Cigarette smoking tends to lower Apo A1 and HDL. Moderate alcohol intake can raise HDL and may increase Apo A1, but alcohol is not recommended as a treatment and may not be safe for everyone.
Insulin resistance, type 2 diabetes, obesity, and high triglycerides are often associated with lower Apo A1. Improving weight, nutrition quality, and physical activity can help.
Because Apo A1 is made in the liver and cleared in part by the kidneys, liver disease and nephrotic-range kidney disease can change levels. Your clinician will consider other liver and kidney tests when interpreting results.
Pregnancy and estrogen-containing contraceptives can increase Apo A1. If you are pregnant or using hormonal therapy, let your clinician know so results are interpreted in context.
References